Pharma Focus Asia
KP - Sustainable Packaging Solutions

FUJIFILM Diosynth Biotechnologies Unveils US$200 million to Open New Manufcaturing Capacity in USA

Introduction:

FUJIFILM Diosynth Biotechnologies invests US$200 million to open new facility to expand cell therapy capabilities in USA.

Features:

The facility will support the construction of a 175,000 square feet. This new facility will become a hub for life science enterprises and academic institutions.

This investment will enhance Fujifilm's manufacturing capacity to facilitate iPSC-derived cell therapies, along with supporting Cytotoxic T lymphocyte (CTL), Chimeric Antigen Receptor (CAR), T-cell Receptor (TCR), Natural Killer (NK), and tissue-derived therapies.

Within the new campus, there will be dedicated space for iPSC cGMP manufacturing, featuring three clean room suites, process development laboratories, warehouse facilities, and administrative areas.

The investment will effectively double the current manufacturing capacity, crucial for advancing iPSC-derived cell therapies from development to commercialisation. 

Additionally, the new site will encompass iPSC manufacturing tailored for research and development purposes, catering to drug discovery, assessing drug efficacy, and advancing pharmacology studies.

The complete site, encompassing cell therapy manufacturing, is scheduled to commence operations in spring 2026.

Specifications:

Name     FUJIFILM Diosynth Biotechnologies
Type       New Construction
Budget  US$200 million
Year        2026

Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024Gibco Adherent Kidney Media PanelAsia Healthcare Week 2024Equinix accelerated medical research...CPHI Korea 2024CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?